If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACC.L Regulatory News (ACC)

  • There is currently no data for ACC

Trading Update

9 Dec 2020 17:31

RNS Number : 1355I
Access Intelligence PLC
09 December 2020
 

Prior to publication, certain information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

Access Intelligence plc

("Access Intelligence" or the "Company")

Trading Update

 

 

Access Intelligence (AIM: ACC), the technology innovator delivering Software-as-a-Service ("SaaS") solutions for the PR, communications and marketing industries, announces an update on trading for year ended 30 November 2020.

 

The Company's growth rate has more than doubled in the second half of the year with strong new business and renewal rates underpinning excellent growth in Annual Contract Value ('ACV') of £2.82m. This compares to ACV growth of £1.06m in the first six months of the financial year, with all sub-brands seeing growth acceleration in the second half. New business sales in the year increased by 95 per cent. year on year and upsell increased by 52 per cent. year on year. Total ACV at 30 November 2020 was approximately £21.9 million.

 

New clients wins in the second half include Amazon, Automobili Lamborghini, Boots, British Retail Consortium, Comic Relief, European Food Safety Authority, Hulu, LinkedIn, Linklaters, McLaren Racing, Publicis, Saatchi & Saatchi, Unicredit and Veolia. The wins continue to demonstrate the increasing appeal of the Company's product portfolio across different sectors and territories.

 

The Board expect that total revenue for the financial year will be in the order of £19.1 million, compared to £13.4 million for the prior year.

 

Given the circumstances created by COVID 19, the year saw the board take a number of cost saving initiatives including the Company furloughing approximately 15% of staff, salary and fee reductions for the Board and employees for three months, and the curtailment of discretionary spending. Notwithstanding the global economic challenges faced in the year, the Board is delighted with the excellent growth trajectory demonstrated by the Company in the year and the Board remains focused on delivering against the longer-term growth opportunity. As part of this strategy the Board actively looks to explore new business opportunities through product enhancement and new technologies to complement the Group's suite of products. This strategy seeks to deliver organic growth complemented by acquisitions to capitalise on opportunities which enable the Group to accelerate its market position. In the course of this year, the Company has incurred non recurring costs of £2.4m including £1.2m of costs incurred as it evaluated potential M&A activity in-line with this strategy.

 

The Company continues to be in a good financial position and as at 30 November, net cash was approximately £1.4 million. In order to underpin the Group's finances and provide additional liquidity, the Company has secured a £2 million, three year facility under the Coronavirus Business Interruption Loan Scheme (CBILS). The facility can be drawn down during December 2020, has a 12-month interest-free period following drawdown and an interest rate of 2.03% plus LIBOR or replacement benchmark rate per annum on the drawn down amount thereafter. The funds are repayable in equal monthly instalments over 36 months and there will be no penalty for making early repayment of the facility. In addition, as the Company looks to accelerate its growth, the Company is separately announcing a placing to raise approximately £10 million today.

 

Christopher Satterthwaite, Non-Executive Chairman of the Company, said: 

"We reported 10% organic ACV growth in 2019 and saw that rise to 12% in the first half of 2020, in spite of the global COVID pandemic. Delivering annualised ACV growth of 30% in the second half of 2020 is an excellent achievement.

 

We've achieved these results thanks to colleagues adapting quickly and readily to new ways of working in challenging circumstances. I cannot praise their energy, focus and flexibility highly enough.

 

This positive performance demonstrates the strength of our product portfolio and our increasing global market presence.

 

We will be starting the financial year 2021 with confidence and a strong pipeline of opportunities."

 

For further information:

Access Intelligence plc 020 3426 4024

Joanna Arnold (CEO) / Mark Fautley (CFO)

finnCap Limited (Nominated Adviser and Broker) 020 7220 0500

Corporate Finance:

Marc Milmo / Kate Bannatyne / Kate Washington

Corporate Broking:

Alice Lane / Sunila de Silva

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSSFWUESSEDE
Date   Source Headline
7th May 20244:21 pmRNSCONFIRMATION OF NAME CHANGE & AIM RULE 26 WEBPAGE
19th Apr 20244:57 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSProposed Change of Name
25th Mar 20247:00 amRNSAccelerating ARR growth for Q1 2024
16th Jan 20247:00 amRNSTrading Update
18th Oct 20237:00 amRNSSignificant customer contract wins in ANZ
4th Jul 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNSTrading Update
23rd May 20232:30 pmRNSResult of Annual General Meeting
10th May 20235:45 pmRNSHolding(s) in Company
21st Apr 20233:00 pmRNSPosting of notice of AGM
17th Apr 20237:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2022
13th Mar 20237:00 amRNSSilicon Valley Bank
3rd Mar 20237:00 amRNSBoard Changes
10th Feb 20237:00 amRNSContract wins
8th Feb 20233:45 pmRNSHolding(s) in Company
30th Jan 202312:25 pmRNSHolding(s) in Company
21st Dec 20221:43 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSTrading Update
28th Jul 20223:45 pmRNSExercise of Options, Treasury Shares & TVR
5th Jul 20227:00 amRNSInterim Results
1st Jul 20227:00 amRNSTotal Voting Rights
17th Jun 20227:00 amRNSTrading Update
14th Jun 20229:40 amRNSHolding(s) in Company
25th May 20223:15 pmRNSResult of Annual General Meeting
29th Apr 20225:00 pmRNSPosting of Notice of AGM
25th Apr 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2021
7th Apr 20227:00 amRNSContract Wins
6th Apr 20222:52 pmRNSHolding(s) in Company
6th Apr 202212:30 pmRNSHolding(s) in Company
25th Feb 202212:15 pmRNSDirector/PDMR Shareholding
4th Feb 20226:01 pmRNSHolding(s) in Company
18th Jan 202212:45 pmRNSDirector/PDMR Shareholding
17th Jan 20224:05 pmRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Update
1st Dec 20217:00 amRNSTotal Voting Rights
18th Nov 20218:00 amRNSHolding(s) in Company
9th Nov 20214:10 pmRNSExercise of Warrants and Total Voting Rights
18th Oct 20218:15 amRNSCopyright Tribunal Ruling
4th Oct 20217:00 amRNSBoard Changes
4th Oct 20217:00 amRNSEstablishment of Long-Term Value Creation Plan
7th Sep 20216:01 pmRNSHolding(s) in Company
7th Sep 202110:50 amRNSHolding(s) in Company
3rd Sep 20215:51 pmRNSHolding(s) in Company
3rd Sep 20215:50 pmRNSHolding(s) in Company
2nd Sep 20218:15 amRNSCompletion of Acquisition and Re-Admission
1st Sep 20218:00 amRNSSuccessful Implementation of Scheme of Arrangement
27th Aug 20219:05 amRNSHolding(s) in Company
27th Aug 20217:00 amRNSHolding(s) in Company
25th Aug 202112:20 pmRNSPosting of Supplementary AIM Admission Document

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.